Skip Navigation



Annals of Oncology Advance Access published online on March 17, 2009

Annals of Oncology, doi:10.1093/annonc/mdn785
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
20/7/1257    most recent
mdn785v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Planchard, D.
Right arrow Articles by Fouret, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Planchard, D.
Right arrow Articles by Fouret, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

The NER proteins are differentially expressed in ever smokers and in never smokers with lung adenocarcinoma

D. Planchard1,2, J. Domont1, E. Taranchon2, I. Monnet3, J. Tredaniel4, R. Caliandro5, P. Validire6, B. Besse1, J.-C. Soria1,7 and P. Fouret2,8,*

1 Medical Oncology and Translational Research, Institut de Cancérologie Gustave Roussy,Villejuif
2 Medical Oncology, Institut de Cancérologie Gustave Roussy,Villejuif
3 Department of Pneumology Creteil, Intercommunal Hospital of Creteil, Creteil
4 Department of Pneumology, Saint-Louis Hospital, Paris
5 Department of Thoracic Disease, Institut Mutualiste Montsouris, Paris
6 Department of Pathology, Institut Mutualiste Montsouris, Paris
7 Department of Medical Oncology, Institut Gustave Roussy, Villejuif
8 Department of Pathology, Institut de Cancérologie Gustave Roussy,Villejuif, France

* Correspondence to: Dr P. Fouret, Department of Translational Research, Institut de Cancérologie Gustave Roussy, 94805 Villejuif Cedex, France. Tel: +33-142116510; Fax: +33-142116094; E-mail: pierre.fouret{at}igr.fr

Background: The expression levels of excision repair cross-complementation group 1 (ERCC1), replication protein A (RPA) and xeroderma pigmentosum group F (XPF) nucleotide excision repair proteins may be important in the response to platin-based therapy in lung cancer patients. It is not known whether ERCC1, RPA and XPF expression levels differ between ever smokers (ES) and never smokers (NS).

Patients and methods: ERCC1, RPA and XPF expression levels were immunohistochemically evaluated in 125 patients with resected lung adenocarcinoma (AC) and carefully reviewed smoking status.

Results: ERCC1 was correlated with XPF (P = 0.001), but not with RPA (P = 0.11). In the univariate analysis, ERCC1 and XPF levels were higher in NS compared with ES (P = 0.004 and P = 0.003, respectively). In the multivariate analysis, the smoking status was predictive of the ERCC1 level [odds ratio (OR) 2.5, 95% confidence interval (CI) 1.03–6.2] after adjustment for variables linked to the smoking status, including age and the presence of bronchioloalveolar (BAC) features. The smoking status was also predictive of both RPA (OR 6.7, 95% CI 1.5–33.3) and XPF levels (OR 12.5, 95% CI 2.9–50) after adjusting for age, sex and BAC features.

Conclusion: In patients with resected lung AC, ERCC1, RPA and XPF expression levels are higher in NS compared with ES.

ERCC1, immunohistochemistry, lung adenocarcinoma, NER, never smoker

Received for publication September 21, 2008. Revision received December 3, 2008. Accepted for publication December 5, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.